PhaseV scores $50M for AI clinical trial platform
Israeli startup PhaseV, an AI-enabled clinical development company for life sciences, has secured $50 million in Series A funding in a round co-led by Accel and Insight Partners. Existing investors Viola Ventures, LionBird and EXOR…
Continue Reading